SCHEMBL5051902

SCHEMBL5051902

Clc1ccc(-c2nn(C34CC5CC(CC(C5)C3)C4)nc2-c2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.54
MAPK1 P28482 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
GAA P10253 2/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP1A2 P05177 1/20 0.40
PTGS1 P23219 3/20 0.38
PTGS2 P35354 3/20 0.38
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPSR1 Q6W5P4 3/20 0.37
HSD11B1 P28845 1/20 0.37
NPC1 O15118 2/20 0.36
NR1H2 P55055 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5049371 0.76 CNR1 (0.49) HSD11B1
SCHEMBL5051904 0.73 GAA (0.42) GAAKDM4ELMNAL3MBTL1CYP1A2
SCHEMBL31005178 0.68 HTT (0.54) TSHRMAPK1SMN1; SMN2GAAKDM4E
SCHEMBL13307797 0.67 CNR1 (0.70) TSHRSMN1; SMN2GAAKDM4ELMNA
SCHEMBL5053646 0.66 MEN1 (0.55) SMN1; SMN2GAAKDM4ELMNAL3MBTL1
SCHEMBL3781020 0.65 SMN1; SMN2 (0.50) TSHRMAPK1SMN1; SMN2KDM4EALDH1A1
SCHEMBL1232285 0.65 SMN1; SMN2 (0.50) TSHRMAPK1SMN1; SMN2KDM4EALDH1A1
SCHEMBL12314560 0.65 SMN1; SMN2 (0.50) TSHRMAPK1SMN1; SMN2KDM4ECYP1A2
SCHEMBL24422087 0.64 CYP1A2 (0.43) SMN1; SMN2GAALMNAL3MBTL1CYP1A2
SCHEMBL26360990 0.64 CYP1A2 (0.43) SMN1; SMN2GAALMNAL3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP claimed
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP disclosed